Preliminary analysis of immune responses in patients enrolled in a Phase II trial of Cyclophosphamide with Allogenic DRibble Vaccine Alone (DPV-001) or with GM-CSF or Imiquimod for adjuvant treatment of Stage IIIA or IIIB NSCLC

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunother Cancer
Main Authors: Hilton, Traci, Sanborn, Rachel, Boulmay, Brian, Li, Rui, Spieler, Bradley, Happel, Kyle, Paustian, Christopher, Moudgil, Tarsem, Dubay, Christopher, Fisher, Brenda, Mederos, Eileen, Ochoa, Augusto, Urba, Walter J, Hu, Hong-Ming, Fox, Bernard
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Poster Presentation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4292542/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2051-1426-2-S3-P249
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados